Antibody data
- Antibody Data
- Antigen structure
- References [3]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 66291-1-Ig - Provider product page
- Provider
- Proteintech Group
- Product name
- HSPA2 antibody
- Antibody type
- Monoclonal
- Description
- HSPA2 antibody (Cat. #66291-1-Ig) is a mouse monoclonal antibody that shows reactivity with human, rat, mouse and has been validated for the following applications: IHC, WB,ELISA.
- Reactivity
- Human, Mouse, Rat
- Host
- Mouse
- Conjugate
- Unconjugated
- Isotype
- IgG
- Antibody clone number
- 1A4A9
- Vial size
- 20ul, 150ul
Submitted references Sex-Related Differences in Protein Expression in Sarcomere Mutation-Positive Hypertrophic Cardiomyopathy.
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations.
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy.
Schuldt M, Dorsch LM, Knol JC, Pham TV, Schelfhorst T, Piersma SR, Dos Remedios C, Michels M, Jimenez CR, Kuster DWD, van der Velden J
Frontiers in cardiovascular medicine 2021;8:612215
Frontiers in cardiovascular medicine 2021;8:612215
Multi-omics integration identifies key upstream regulators of pathomechanisms in hypertrophic cardiomyopathy due to truncating MYBPC3 mutations.
Pei J, Schuldt M, Nagyova E, Gu Z, El Bouhaddani S, Yiangou L, Jansen M, Calis JJA, Dorsch LM, Blok CS, van den Dungen NAM, Lansu N, Boukens BJ, Efimov IR, Michels M, Verhaar MC, de Weger R, Vink A, van Steenbeek FG, Baas AF, Davis RP, Uh HW, Kuster DWD, Cheng C, Mokry M, van der Velden J, Asselbergs FW, Harakalova M
Clinical epigenetics 2021 Mar 23;13(1):61
Clinical epigenetics 2021 Mar 23;13(1):61
Protein Quality Control Activation and Microtubule Remodeling in Hypertrophic Cardiomyopathy.
Dorsch LM, Schuldt M, dos Remedios CG, Schinkel AFL, de Jong PL, Michels M, Kuster DWD, Brundel BJJM, van der Velden J
Cells 2019 Jul 18;8(7)
Cells 2019 Jul 18;8(7)
No comments: Submit comment
No validations: Submit validation data